LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma : Implications for therapeutic drug monitoring

Simple item page
dc.contributor.authorKivrane, Agnija
dc.contributor.authorGrinberga, Solveiga
dc.contributor.authorSevostjanovs, Eduards
dc.contributor.authorIgumnova, Viktorija
dc.contributor.authorPole, Ilva
dc.contributor.authorViksna, Anda
dc.contributor.authorBandere, Dace
dc.contributor.authorKrams, Alvils
dc.contributor.authorCirule, Andra
dc.contributor.authorPugovics, Osvalds
dc.contributor.authorRanka, Renate
dc.contributor.institutionRīga Stradiņš University
dc.date.accessioned2021-11-16T08:10:03Z
dc.date.available2021-11-16T08:10:03Z
dc.date.issued2021-11-15
dc.descriptionFunding Information: This study was funded by the Latvian Council of Science. Project No: lzp-2020/1-0050. Publisher Copyright: © 2021 The Authors
dc.description.abstractThe pharmacokinetic profiling of drug substances and corresponding metabolites in the biological matrix is one of the most informative tools for the treatment efficacy assessment. Therefore, to satisfy the need for comprehensive monitoring of anti-tuberculosis drugs in human plasma, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for simultaneous quantification of first-line anti-tuberculosis drugs (ethambutol, isoniazid, pyrazinamide, and rifampicin) along with their six primary metabolites. Simple single-step protein precipitation with methanol was chosen as the most convenient sample pre-treatment method. Chromatographic separation of the ten analyte mixture was achieved within 10 minutes on a reverse-phase C8 column using mobile phase gradient mode. The multiple reaction monitoring mode (MRM) was used for analyte detection and quantification in patient samples. The chosen quantification ranges fully covered expected plasma concentrations. The method exhibited acceptable selectivity; the within- and between-run accuracy ranged from 87.2 to 113.6%, but within- and between-run precision was between 1.6 and 14.9% (at the LLOQ level CV < 20%). Although the response of the isonicotinic acid varied depending on the matrix source (CV 21.8%), validation results proved that such inconsistency does not affect the accuracy and precision of results. If stored at room temperature plasma samples should be processed within 4 h after collection, temporary storage at −20 °C up to 24 h is acceptable due to stability issues of analytes. The developed method was applied for the patient sample analysis (n = 34) receiving anti-tuberculosis treatment with the first-line drugs.en
dc.description.statusPeer reviewed
dc.format.extent1098667
dc.identifier.citationKivrane, A, Grinberga, S, Sevostjanovs, E, Igumnova, V, Pole, I, Viksna, A, Bandere, D, Krams, A, Cirule, A, Pugovics, O & Ranka, R 2021, 'LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma : Implications for therapeutic drug monitoring', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 1185, 122986. https://doi.org/10.1016/j.jchromb.2021.122986
dc.identifier.doi10.1016/j.jchromb.2021.122986
dc.identifier.issn1570-0232
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6834
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85117567865&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLC-MS/MS
dc.subjectPharmacokinetics
dc.subjectTherapeutic drug monitoring
dc.subjectTuberculosis
dc.subject1.4 Chemical sciences
dc.subject3.1 Basic medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectAnalytical Chemistry
dc.subjectBiochemistry
dc.subjectClinical Biochemistry
dc.subjectCell Biology
dc.subjectSDG 3 - Good Health and Well-being
dc.titleLC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma : Implications for therapeutic drug monitoringen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Method_for_simultaneous_quantification.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure